Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2026-03-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
关于提请股东会授权董事会办理以简易程序向特定对象发行股票的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding a proposal to authorize the board of directors to handle a simplified procedure for issuing shares to specific investors. It details the terms, conditions, pricing, quantity, and use of proceeds for the share issuance. The document is a formal public announcement about a capital raising activity, specifically a private placement or targeted share issuance. It is not a full financial report, audit report, or earnings release. It is not a proxy statement or voting result announcement, but rather a capital/financing update. The document length is 4687 characters, which is sufficient for a detailed announcement but does not contain financial statements or comprehensive financial analysis. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2026-03-27 Chinese
独立董事2025年度述职报告（刘建伟-已离任）
Management Reports Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for a company, detailing the independent director's attendance at meetings, committee participation, supervisory activities, and compliance with laws and regulations during the 2025 fiscal year. It is a narrative report on the director's duties and activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it an announcement of voting results or management changes. It fits best as a Management Report or similar detailed explanation of governance and oversight activities by management or board members. Given the content and nature, the most appropriate classification is 'Management Reports (MDA)'. The document length is moderate and contains substantive content, not a brief announcement or certification, so it is not RNS or RPA. Confidence is high due to clear alignment with the definition of Management Reports.
2026-03-27 Chinese
拓新药业集团股份有限公司2025年度非经营性资金占用及其他关联资金往来的专项说明
Audit Report / Information Classification · 95% confidence The document is titled as a "专项说明" (special explanation) regarding "2025年度非经营性资金占用及其他关联资金往来" (non-operating fund occupation and other related party fund transactions) for the year 2025. It references the audit of the 2025 financial statements and includes a summary table of related party transactions. The document is issued by an accounting firm with an audit report number and date, indicating it is an audit-related disclosure. The content focuses on a specific audit-related explanation and reconciliation of related party fund transactions, not a full annual report or interim report. It is a standalone audit-related disclosure document, consistent with an Audit Report / Information filing rather than a full Annual Report or other categories. The document length is under 5,000 characters and contains detailed audit-related financial reconciliations and explanations, not just an announcement or certification. Therefore, the best classification is Audit Report / Information (AR). FY 2025
2026-03-27 Chinese
董事会关于独立董事独立性情况的专项意见
Board/Management Information Classification · 95% confidence The document is a special opinion from the Board of Directors regarding the independence of the company's independent directors, referencing regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. It is a governance-related statement about board members' independence, not a financial report, audit, or announcement of voting results. The content fits the category of Board/Management Information (MANG) as it relates to board member status and governance compliance.
2026-03-27 Chinese
2025年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as "2025 年年度报告摘要" which translates to "2025 Annual Report Summary". It contains detailed information about the company's business overview, core technologies, risk factors, financial data for the year 2025, and strategic outlook. The document includes audited financial data, mentions the audit opinion, and provides comprehensive management discussion and analysis of the company's operations and future plans. The length is substantial (15,000 characters), and it is not merely an announcement or a brief summary but a detailed report. Therefore, this document fits the definition of an Annual Report (10-K). FY 2025
2026-03-27 Chinese
关于2026年以简易程序向特定对象发行股票预案披露的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding a plan to issue shares to specific investors using a simplified procedure. It mentions the board meeting approval and regulatory review steps but does not contain financial statements or detailed financial data. The document is short (568 characters) and serves as a notice about a capital raising plan rather than the actual issuance or detailed financial report. Therefore, it fits the category of Capital/Financing Update (CAP).
2026-03-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.